R&G Pharma

301333
51.591.40% ( -0.73 )
Delay Closed: Nov 17, 15:00:00

Financials

Q3 2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: R&G Pharma(301333) the Revenue is 245.83 M (+7.96%);the EBIT is 28.46 M (-22.16%);the EPS is 0.333 (-7.42%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.25B7.96%
----
----
EBIT
0.03B22.16%
----
----
EPS
0.33327.42%
----
----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 26, 2027
Estimate Revenue975 M
Estimate EBIT190 M
Estimate EPS1.73

Revenue

ActualEstimateUnit: CNY
Quarterly

EBIT

ActualEstimateUnit: CNY
Quarterly

Net income

ActualEstimateUnit: CNY
Quarterly

EPS

ActualEstimateUnit: CNY
Quarterly